Cargando…
XANAP: A real‐world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia
BACKGROUND: ROCKET AF and its East Asian subanalysis demonstrated that rivaroxaban was non‐inferior to warfarin for stroke/systemic embolism (SE) prevention in patients with non‐valvular atrial fibrillation (NVAF), with a favorable benefit–risk profile. XANAP investigated the safety and effectivenes...
Autores principales: | Kim, Young‐Hoon, Shim, Jaemin, Tsai, Chia‐Ti, Wang, Chun‐Chieh, Vilela, Gilbert, Muengtaweepongsa, Sombat, Kurniawan, Mohammad, Maskon, Oteh, Li Fern, Hsu, Nguyen, Thang Huy, Thanachartwet, Thititat, Sim, Kenneth, Camm, A. John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111488/ https://www.ncbi.nlm.nih.gov/pubmed/30167013 http://dx.doi.org/10.1002/joa3.12073 |
Ejemplares similares
-
A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea
por: Shim, Jaemin, et al.
Publicado: (2021) -
Medical therapy of a left-sided native valve endocarditis with neurologic sequela
por: Ng, Choon S., et al.
Publicado: (2015) -
Microembolic signal detection by transcranial Doppler: Old method with a new indication
por: Muengtaweepongsa, Sombat, et al.
Publicado: (2018) -
Targeted temperature management in neurological intensive care unit
por: Muengtaweepongsa, Sombat, et al.
Publicado: (2017) -
Hypothermia treatment reduced cyclin-dependent kinase 5-mediated inflammation in ischemic stroke and improved outcomes in ischemic stroke patients
por: Muengtaweepongsa, Sombat, et al.
Publicado: (2020)